Ricevi le ultime notizie sulle azioni 10x Genomics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di TXG

Ultime notizie per

10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Russia,Moscow,24.06.2021,Logo,Of,Financial,Investing,Fund,Ark,Invest

Equities

News

Markets

ETFs

ARKK

ARKW

ARKX

CRSP

KTOS

PACB

PLTR

SHOP

Movimenti sui fondi ETF della nota investitrice. Cessioni del titolo AI, acquisti mirati su chip ed e-commerce. Attività anche su biotech.

Cathie Wood vende Palantir prima degli utili e acquista questi 2 titoli

Stuttgart,,Germany,-,03-11-2021:,Person,Holding,Cellphone,With,Company,Logo

ADPT

ARKQ

NRIX

NVDA

PATH

Nuovi acquisti per il fondo guidato dalla celebre investitrice, focus su un settore chiave. Ribilanciamento in corso nel portafoglio.

Cathie Wood non si ferma più: Ark Invest compra ancora questi titoli

10x Genomics Inc

TEXAS GULF ENERGY INC by Texas Gulf Energy, Incorporated.

Texas Gulf Energy Inc

TEXGEN PWR LLC by TEXGEN PWR LLC

Press Releases

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

10x Genomics to Acquire Scale Biosciences

Earnings

10x Genomics Reports Second Quarter 2025 Financial Results

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

10x Genomics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO